AG
OPRX icon

Algert Global’s OptimizeRx OPRX Stock Holding History

Algert Global’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,630
Closed -$181K – 1211
2023
Q4 		$181K Buy
+12,630
New +$121K 0.01% 1034
2023
Q3 		– Sell
-11,970
Closed -$171K – 1212
2023
Q2 		$171K Buy
+11,970
New +$170K 0.01% 999

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

Algert Global's OPRX Position: Q1 2024 in Review

Algert Global sold out of OptimizeRx (OPRX) in Q1 2024, closing a stake of 12,630 shares — an estimated $181K sold.

Algert Global first reported a position in OPRX in Q2 2023 and held it in 2 quarters. The position peaked at $181K in Q4 2023. 97 funds tracked by Wall St. Rank hold OPRX as of Q1 2024.

  • Algert Global reported no remaining OptimizeRx position as of Q1 2024 after selling out during the quarter.
  • Algert Global sold 12,630 OptimizeRx shares in Q1 2024, an estimated $181K.
  • Algert Global first reported a position in OptimizeRx in Q2 2023 and held it in 2 quarters.
  • Algert Global's OptimizeRx position peaked at $181K in Q4 2023.
  • 97 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2024.

Based on Algert Global's 13F filing for Q1 2024, filed 15 May 2024.